The broader enforcement focus: Botox-type products, ophthalmics, clinical trials, recalls The RAPS article also highlights other key enforcement priorities for CDER in 2025: The agency issued 18 warning letters to firms marketing fraudulent or unapproved Botox-type products, warning that such products pose serious safety risks, including potential counterfeiting, incorrect/inactive ingredients, or falsification
Plus my GP surgery took me off B12 and thats why I self injecting as I couldnt manage without it, however they dont think I should be and its hard to explain to them why I do, they act like Ive told them I inject crack cocaine when I have good reasons for injecting B12 but cant prove it as obviously my B12 comes up sky high in a blood test
June 15, 2023 Novo Nordisk and FDA announce counterfeit Ozempic has been found in the U.S
Athletes and Active Individuals: Enhanced detoxification and improved cellular energy support faster recovery and overall vitality
We performed a hierarchical cluster analysis of differentially expressed genes (DEGs) to evaluate gene expression patterns between groups and samples